{"has_more":true,"total_items":28,"items":[{"reference_info":"Texas Intellectual Property Law Journal, Vol. 25, P. 39, 2017, U of Penn, Inst for Law & Econ Research Paper No. 17-30","posted_date":"23 Apr 2016","authors":[{"author_name":"Erik Hovenkamp","author_url":"https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=1009772"},{"author_name":"Herbert Hovenkamp","author_url":"https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=23858"}],"fullTextUrl":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3129018_code711466.pdf?abstractid=2767098","revised_date":"23 Feb 2018","ssrn_abstract_id":2767098,"vg_id":927662,"abstract_url":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2767098","title":"Buying Monopoly: Antitrust Limits on Damages for Externally Acquired Patents","in_myLibrary":0,"downloads":281,"pdf_pages":35,"is_fee":false,"doi":"https://doi.org/10.2139/ssrn.2767098"},{"vg_id":0,"volume":36,"authors":[{"author_name":" Eo"}]},{"vg_id":0,"journal":"A. § 355(j)(5)(B)(iv)","authors":[{"author_name":"U S C"}]},{"vg_id":0,"published_date":"2020-07-30","journal":"re Humira Antitrust Litigation, 465 F.Supp.3d 811 (N.D.Il. 2020), app. docketed 7 th Cir","title":"Noerr-Pennington doctrine precluded antitrust liability where roughly half of the patents that the defendant asserted were found to be valid). Cf. Biocad JSC v. Hoffman-La Roche, 942 F.3d 88 (2d Cir. 2019) (foreign manufacturers failed to show that their claim that defendant's scheme to exclude biosimilar drugs fell within exclusion of the Foreign Trade Antitrust Improvements Act, 15 U.S.C. §6a, given that in the first instance the injuries accrued entirely to foreign firms). The problem of antitrust and new entry by biosimilars is","authors":[{"author_name":"E G Herbert"},{"author_name":"Mark D Hovenkamp"},{"author_name":"Mark A Janis"},{"author_name":"Christopher Lemley"},{"author_name":" Leslie"},{"author_name":" Michael Carrier"}]}]}